Pediatric Ventricle Function Assessment Study
1 other identifier
observational
3,993
1 country
1
Brief Summary
This study aims to develop a deep learning-based framework for right ventricular (RV) segmentation, prediction of RV fractional area change (FAC), and identification of pediatric RV dysfunction. The AI model was designed to distinguish between normal pediatric hearts, pulmonary hypertension (PH), and Tetralogy of Fallot (TOF). To improve diagnostic accuracy, the investigators extended the analysis beyond the A4C view by integrating data from both A4C and PSAX views. Additionally, the framework was applied to predict left ventricular ejection fraction (LV EF), further showcasing its versatility and clinical utility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedFirst Submitted
Initial submission to the registry
December 12, 2024
CompletedFirst Posted
Study publicly available on registry
December 18, 2024
CompletedDecember 20, 2024
December 1, 2024
10.7 years
December 12, 2024
December 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
RV dysfunction prediction
FAC \< 35% is considered RV abnormal. The automated extracted FAC values were then used to predict the probability of abnormal RV function.FAC estimation accuracy was evaluated using mean absolute error (MAE), root mean squared error (RMSE), and Pearson correlation coefficient (R). Diagnostic performance metrics included AUC, sensitivity, and specificity for RV function assessment
10 minutes
Congenital Heart Disease Detection
For CHD detection, classification models were developed to distinguish between normal, PH, and TOF cases by analyzing RV echocardiogram videos. Accuracy, sensitivity, and specificity were used to evaluate the classifications of PH versus normal and PH versus TOF
10 minutes
Left Ventricle Dysfunction
The performance is assessed by calculating the area under the receiver operating characteristic (ROC) curve , evaluating the model's accuracy in detecting abnormal EF values.
10 minutes
Study Arms (4)
RV FAC Prediction Cohort
This cohort is designed to predict pediatric RV FAC using a deep learning model based on echocardiograms
RV Disease Classification Cohort
The cohort is designed to employ a deep learning model to differentiate between normal pediatric hearts and pulmonary hypertension (PH), as well as between Tetralogy of Fallot (TOF) and PH, using echocardiograms.
RV Function Assessment and Disease Classification Using A4C and PSAX View Cohorts
The cohort is designed to utilize A4C and PSAX echocardiographic views for pediatric RV function assessment and disease classification using deep learning models.
LV Ejection Fraction (EF) Prediction Cohort
The cohort is designed to validate our new deep learning model for LV EF assessment.
Eligibility Criteria
Two groups of children are included. Group I: Children with normal right ventricular anatomy and function assessment based on screening echocardiograms and physcian follow up. Group II: Children with right ventricular abnormalities who have potential risk of adverse outcomes.
You may qualify if:
- Patients aged 0-18 years old.
- Patients with the following diagnoses (defined as abnormal RVs): premature infants with lung disease, congenital heart disease with systemic right ventricles, surgically repaired congenital heart disease resulting in pressure and/or volume load on the RV (tetralogy of Fallot, Double outlet right ventricle, etc.), and idiopathic pulmonary hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Cardiothoracic Surgery (Pediatric Cardiac Surgery) and of Pediatrics (Cardiology), Stanford University School of Medicine
Study Record Dates
First Submitted
December 12, 2024
First Posted
December 18, 2024
Study Start
January 1, 2014
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
December 20, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share